243
Views
1
CrossRef citations to date
0
Altmetric
Articles

Biologically active mixed ligand complexes of Co(II), Ni(II), Cu(II) and Zn(II) as potential antimalarial, antidibetic and anticancer agents

, &
Pages 1234-1242 | Received 10 Jun 2021, Accepted 16 Jan 2022, Published online: 23 Feb 2022
 

Abstract

Mixed ligand complexes of transition metal ions Co(II), Ni(II), Cu(II) and Zn(II) were synthesized using bidentate Schiff’s base (E)-2-((benzo[d]thiazol-2-yliminomethyl)-6-methoxyphenol (L1), derived from condensation reaction of 2-aminobenzothiazole and 2-hydroxy-3-methoxybenzaldehyde, and 5-Chloro-8-hydroxyquinoline (5CHQ) (L2) as ligands. All the synthesized compounds were characterized using elemental analysis, IR, electronic, 1H and 13C NMR spectra, TGA-DTA and Powder XRD analysis, molar conductivity and magnetic susceptibility measurements. Based on the results obtained all the synthesized complexes are proposed to have tetrahedral geometry. All the synthesized compounds were screened for their antioxidant, antimicrobial, antimalarial, antidibetic, anticancer activities and cytotoxicity study using MTT assay. The complexes are proposed to have potential antimalarial, antidibetic and anticancer activities.

Graphical Abstract

Disclosure statement

All authors declare no conflict of interest including financial, personal or other relationships with other people or organizations for this article.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.